Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,451 | 22,168 | 24,314 | 24,674 | 7,097 |
| Receivables | 276 | 357 | 104 | 357 | 309 |
| TOTAL | $21,994 | $22,529 | $24,704 | $25,037 | $7,469 |
| Non-Current Assets | |||||
| PPE Net | 324 | 140 | 152 | 147 | 150 |
| Intangibles | 526 | 570 | 624 | 649 | 674 |
| Other Non-Current Assets | 446 | 477 | 0 | 0 | 0 |
| TOTAL | $1,297 | $1,187 | $776 | $797 | $824 |
| Total Assets | $23,291 | $23,716 | $25,480 | $25,833 | $8,292 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,502 | 1,080 | 884 | 1,044 | 685 |
| TOTAL | $1,599 | $1,174 | $884 | $1,044 | $685 |
| Non-Current Liabilities | |||||
| TOTAL | $192 | $220 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,790 | $1,393 | $884 | $1,044 | $685 |
| Shareholders' Equity | |||||
| Common Shares | 59,570 | 58,861 | 59,838 | 57,715 | 40,353 |
| Retained earnings | -47,522 | -43,542 | -42,769 | -40,484 | -38,292 |
| Other shareholders' equity | 2,809 | 2,937 | 3,004 | 2,936 | 1,167 |
| TOTAL | $21,500 | $22,323 | $24,595 | $24,789 | $7,607 |
| Total Liabilities And Equity | $23,291 | $23,716 | $25,480 | $25,833 | $8,292 |